Subject(s)
Communicable Diseases, Emerging , Disease Outbreaks , Humans , Communicable Diseases, Emerging/epidemiology , Communicable Diseases, Emerging/virology , Global Health , Public Health , Bunyaviridae Infections/epidemiology , Arbovirus Infections/epidemiology , Arbovirus Infections/virology , OrthobunyavirusSubject(s)
Physicians , Humans , Physicians/psychology , Bunyaviridae Infections , Orthobunyavirus , AnimalsABSTRACT
Beginning in late 2023, Oropouche virus was identified as the cause of large outbreaks in Amazon regions with known endemic transmission and in new areas in South America and the Caribbean. The virus is spread to humans by infected biting midges and some mosquito species. Although infection typically causes a self-limited febrile illness, reports of two deaths in patients with Oropouche virus infection and vertical transmission associated with adverse pregnancy outcomes have raised concerns about the threat of this virus to human health. In addition to approximately 8,000 locally acquired cases in the Americas, travel-associated Oropouche virus disease cases have recently been identified in European travelers returning from Cuba and Brazil. As of August 16, 2024, a total of 21 Oropouche virus disease cases were identified among U.S. travelers returning from Cuba. Most patients initially experienced fever, myalgia, and headache, often with other symptoms including arthralgia, diarrhea, nausea or vomiting, and rash. At least three patients had recurrent symptoms after the initial illness, a common characteristic of Oropouche virus disease. Clinicians and public health jurisdictions should be aware of the occurrence of Oropouche virus disease in U.S. travelers and request testing for suspected cases. Travelers should prevent insect bites when traveling, and pregnant persons should consider deferring travel to areas experiencing outbreaks of Oropouche virus disease.
Subject(s)
Bunyaviridae Infections , Humans , United States/epidemiology , Female , Adult , Male , Bunyaviridae Infections/epidemiology , Middle Aged , Aged , Orthobunyavirus/isolation & purification , Travel , Young Adult , Travel-Related Illness , Disease Outbreaks , Cuba/epidemiologyABSTRACT
Orientaciones sobre el diagnóstico y vigilancia por laboratorio de arbovirus emergentes, incluyendo OROV, se detallan en las “Directrices para la Detección y Vigilancia de Arbovirus Emergentes en el Contexto de la Circulación de Otros Arbovirus”
Subject(s)
Bunyaviridae Infections/diagnosis , Epidemiologic Surveillance Services , Bunyaviridae Infections/congenital , OrthobunyavirusABSTRACT
O site atua como uma plataforma central para conectar cidadãos, profissionais de saúde, pesquisadores e gestores públicos, facilitando o acesso a informações e serviços essenciais para a saúde no Brasil. informações atualizadas sobre políticas, programas e ações de saúde pública, além de dados epidemiológicos e estatísticas de saúde. Campanhas de conscientização sobre prevenção de doenças, saúde da mulher, saúde infantil, saúde do idoso, entre outras áreas. Legislação e Regulamentação: Publicar e atualizar normas, portarias, resoluções e diretrizes relacionadas ao sistema de saúde e à prática médica no Brasil, etc
Subject(s)
Bunyaviridae Infections/prevention & control , Orthobunyavirus , Insecta/virology , Ceratopogonidae/virologyABSTRACT
O site da FIOCRUZ (Fundação Oswaldo Cruz) oferece uma ampla gama de conteúdos e funcionalidades relacionadas à saúde pública, pesquisa científica, educação e desenvolvimento tecnológico.
Subject(s)
Bunyaviridae Infections/prevention & control , Sanitary Control of Borders , Orthobunyavirus , Disease NotificationABSTRACT
Washington D.C., 24 de julho de 2024 (OPAS) [Atualizado em 26 de julho de 2024] – Em julho deste ano, a Organização Pan-Americana da Saúde (OPAS) emitiu alerta epidemiológico sobre um aumento nos casos notificados do vírus Oropouche (OROV) em cinco países (Brasil, Bolívia, Peru, Cuba e Colômbia) na Região das Américas. Washington D.C., 24 de julio de 2024 (OPS) [Actualizado el 26 de julio de 2024] – En julio de este año, la Organización Panamericana de la Salud (OPS) emitió una alerta epidemiológica sobre un aumento de casos reportados del virus Oropouche (OROV) en cinco países (Brasil, Bolivia, Perú, Cuba y Colombia) de la Región de las Américas. Washington D.C., 24 July 2024 (PAHO) [Updated 26 July 2024] – In July this year, the Pan American Health Organization (PAHO) issued an epidemiological alert on an increase in reported cases of Oropouche virus (OROV) in five countries (Brazil, Bolivia, Peru, Cuba and Colombia) in the Region of the Americas.
Subject(s)
Bunyaviridae Infections/virology , Orthobunyavirus , Bunyaviridae Infections/epidemiology , Bunyaviridae Infections/prevention & control , Disease Outbreaks/prevention & controlABSTRACT
Oropouche virus could be linked to brain malformation and stillbirths, Brazilian health officials say.
Subject(s)
Brain , Bunyaviridae Infections , Infectious Disease Transmission, Vertical , Microcephaly , Orthobunyavirus , Stillbirth , Female , Humans , Pregnancy , Brain/abnormalities , Brain/virology , Brazil/epidemiology , Fetus/virology , Stillbirth/epidemiology , Bunyaviridae Infections/epidemiology , Microcephaly/virologyABSTRACT
The Schmallenberg virus (SBV), an emerging Orthobunyavirus of mainly ruminant hosts, caused a substantial epidemic in European ruminant populations between 2011 and 2013. The pathogen is transmitted by arthropod vectors (Culicoides spp.) and can cause reproductive disorders and severe malformations of the offspring or stillbirth. The present study aimed to assess SBV seroprevalence among German sheep and goats a few years after the first virus detection in the country (November 2011). In addition, an extensive risk factor analysis including host-specific and husbandry-related factors was implemented. Seroprevalence was determined by examining serum samples from 2759 sheep and 446 goats out of a total of 70 flocks across five German federal states. The samples were withdrawn in the period between 2017 and 2018. Using a commercial competitive ELISA, antibodies against SBV were detected in all 70 investigated flocks. A percentage of 60.1â¯% (1657/2759) of the sheep and 40.4â¯% (180/446) of the goat sera contained SBV antibodies. Generalized linear mixed modeling revealed significant effects of host species (sheep > goats), age (old > young) and sex (female > male) on SBV seroprevalence. For both species, also the farming purpose, and for goats, ectoparasite treatment and the presence of cattle on the farm played a role in terms of risk for SBV exposure. The observations from this study still emphasize a wide distribution of the pathogen in Germany. Nevertheless, the observed seroprevalence might not be sufficient to achieve effective herd immunity. Pinpointing risk factors identified susceptible populations for targeted vaccination programs to reduce potential animal losses caused by SBV.
Subject(s)
Bunyaviridae Infections , Goat Diseases , Goats , Orthobunyavirus , Sheep Diseases , Animals , Sheep , Germany/epidemiology , Sheep Diseases/epidemiology , Sheep Diseases/virology , Bunyaviridae Infections/veterinary , Bunyaviridae Infections/epidemiology , Seroepidemiologic Studies , Orthobunyavirus/isolation & purification , Goat Diseases/epidemiology , Goat Diseases/virology , Risk Factors , Female , Male , Animal Husbandry/methods , Antibodies, Viral/bloodABSTRACT
Severe fever with thrombocytopenia syndrome (SFTS) virus, a tick-borne bunyavirus, causes a severe/fatal disease termed SFTS; however, the viral virulence is not fully understood. The viral non-structural protein, NSs, is the sole known virulence factor. NSs disturbs host innate immune responses and an NSs-mutant SFTS virus causes no disease in an SFTS animal model. The present study reports a novel determinant of viral tropism as well as virulence in animal models, within the glycoprotein (GP) of SFTS virus and an SFTS-related tick-borne bunyavirus. Infection with mutant SFTS viruses lacking the N-linked glycosylation of GP resulted in negligible usage of calcium-dependent lectins in cells, less efficient infection, high susceptibility to a neutralizing antibody, low cytokine production in macrophage-like cells, and reduced virulence in Ifnar-/- mice, when compared with wildtype virus. Three SFTS virus-related bunyaviruses had N-glycosylation motifs at similar positions within their GP and a glycan-deficient mutant of Heartland virus showed in vitro and in vivo phenotypes like those of the SFTS virus. Thus, N-linked glycosylation of viral GP is a novel determinant for the tropism and virulence of SFTS virus and of a related virus. These findings will help us understand the process of severe/fatal diseases caused by tick-borne bunyaviruses.
Subject(s)
Glycoproteins , Phlebovirus , Viral Tropism , Animals , Glycosylation , Mice , Virulence , Phlebovirus/pathogenicity , Phlebovirus/genetics , Glycoproteins/metabolism , Glycoproteins/genetics , Humans , Severe Fever with Thrombocytopenia Syndrome/virology , Mice, Inbred C57BL , Bunyaviridae Infections/virology , Bunyaviridae Infections/metabolism , Ticks/virology , Mice, Knockout , Orthobunyavirus/pathogenicity , Orthobunyavirus/genetics , Orthobunyavirus/metabolismABSTRACT
Transmission electron microscopy significantly contributed to unveil the course of virus entry, replication, morphogenesis, and egress. For these studies, the most widely used approach is imaging ultrathin sections of virus-infected cells embedded in a plastic resin that is transparent to electrons. Before infiltration in a resin, cells must be processed to stabilize their components under the observation conditions in an electron microscope, such as high vacuum and irradiation with electrons. For conventional sample preparation, chemical fixation and dehydration are followed by infiltration in the resin and polymerization to produce a hard block that can be sectioned with an ultramicrotome. Another method that provides a superior preservation of cell components is high-pressure freezing (HPF) followed by freeze substitution (FS) before resin infiltration and polymerization. This chapter describes both procedures with cells infected with Bunyamwera virus (BUNV), a well characterized member of the Bunyavirales, and compares the morphological details of different viral structures imaged in the two types of samples. Advantages, disadvantages, and applications of conventional processing and HPF/FS are also presented and discussed.
Subject(s)
Freeze Substitution , Microscopy, Electron, Transmission , Freeze Substitution/methods , Microscopy, Electron, Transmission/methods , Orthobunyavirus , Animals , Freezing , Humans , Specimen Handling/methods , Cell LineABSTRACT
The genome of most bunyaviruses is divided over three (S, M, and L) single-stranded RNA segments of negative polarity. The three viral RNA segments are essential to establish a productive infection. RNA fluorescence in situ hybridization (FISH) enables the detection, localization, and quantification of RNA molecules at single-molecule resolution. This chapter describes an RNA FISH method to directly visualize individual segment-specific bunyavirus RNAs in fixed infected cells and in mature virus particles, using Rift Valley fever virus as an example. Imaging of bunyavirus RNA segments is a valuable experimental tool to investigate fundamental aspects of the bunyavirus life cycle, such as virus replication, genome packaging, and virion assembly, among others.
Subject(s)
Genome, Viral , In Situ Hybridization, Fluorescence , RNA, Viral , In Situ Hybridization, Fluorescence/methods , RNA, Viral/genetics , Single Molecule Imaging/methods , Animals , Virus Replication/genetics , Rift Valley fever virus/genetics , Orthobunyavirus/genetics , HumansABSTRACT
This perspective underscores the rising challenge posed by emerging diseases against the backdrop of modern advancements in global public health understanding. It particularly highlights the emergence of the Oropouche virus (OROV) as a significant global threat, detailing its transmission dynamics, symptoms, and epidemiological impact, with a focus on its historical and current manifestations. It further delves into the molecular aspects of OROV, elucidating its unique characteristics, lack of structural similarity with other arboviruses, and the limited progress in medicinal chemistry research. Still, it highlights notable studies on potential antiviral agents and the challenges in drug development, emphasizing the need for innovative approaches such as structure-based drug design (SBDD) and drug repurposing. Finally, it concludes with a call to action, urging increased attention and research focus on OROV to prevent potential future pandemics fueled by viral mutations.
Subject(s)
Antiviral Agents , Orthobunyavirus , Antiviral Agents/chemistry , Antiviral Agents/pharmacology , Antiviral Agents/therapeutic use , Humans , Bunyaviridae Infections/drug therapy , Animals , Molecular StructureABSTRACT
Oropouche fever is caused by Oropouche virus (OROV), transmitted primarily through the bite of infected midges, particularly of the genus Culicoides. The virus is mainly circulating in Central and South America where several countries reported an ongoing outbreak. We report here two imported cases of OROV infection identified in Italy, late May-early June 2024. These cases indicate that in the shadow of a massive dengue outbreak in the Americas, the Oropouche outbreak might be more widespread than previously estimated.
Subject(s)
Travel , Humans , Italy/epidemiology , Male , Cuba/epidemiology , Adult , Orthobunyavirus/isolation & purification , Animals , Disease Outbreaks , Bunyaviridae Infections/diagnosis , Bunyaviridae Infections/epidemiology , Middle Aged , FemaleABSTRACT
Schmallenberg virus (SBV) belongs to the Simbu serogroup within the family Peribunyaviridae, genus Orthobunyavirus and is transmitted by Culicoides biting midges. Infection of naïve ruminants in a critical phase of gestation may lead to severe congenital malformations. Sequence analysis from viremic animals revealed a very high genome stability. In contrast, sequence variations are frequently described for SBV from malformed fetuses. In addition to S segment mutations, especially within the M segment encoding the major immunogen Gc, point mutations or genomic deletions are also observed. Analysis of the SBV_D281/12 isolate from a malformed fetus revealed multiple point mutations in all three genome segments. It also has a large genomic deletion in the antigenic domain encoded by the M segment compared to the original SBV reference strain 'BH80/11' isolated from viremic blood in 2011. Interestingly, SBV_D281/12 showed a marked replication deficiency in vitro in Culicoides sonorensis cells (KC cells), but not in standard baby hamster kidney cells (BHK-21). We therefore generated a set of chimeric viruses of rSBV_D281/12 and wild-type rSBV_BH80/11 by reverse genetics, which were characterized in both KC and BHK-21 cells. It could be shown that the S segment of SBV_D281/12 is responsible for the replication deficit and that it acts independently from the large deletion within Gc. In addition, a single point mutation at position 111 (S to N) of the nucleoprotein was identified as the critical mutation. Our results suggest that virus variants found in malformed fetuses and carrying characteristic genomic mutations may have a clear 'loss of fitness' for their insect hosts in vitro. It can also be concluded that such mutations lead to virus variants that are no longer part of the natural transmission cycle between mammalian and insect hosts. Interestingly, analysis of a series of SBV sequences confirmed the S111N mutation exclusively in samples of malformed fetuses and not in blood from viremic animals. The characterization of these changes will allow the definition of protein functions that are critical for only one group of hosts.
Subject(s)
Bunyaviridae Infections , Ceratopogonidae , Genome, Viral , Orthobunyavirus , Animals , Orthobunyavirus/genetics , Orthobunyavirus/classification , Orthobunyavirus/isolation & purification , Bunyaviridae Infections/virology , Bunyaviridae Infections/veterinary , Ceratopogonidae/virology , Cricetinae , Cell Line , Virus Replication , Point Mutation , Cattle , Sheep , Phylogeny , RNA, Viral/geneticsABSTRACT
Akabane virus (AKAV) is characterized by abortion, stillbirth, premature birth, and congenital deformities in livestock and is widely distributed throughout Australia, Southeast Asia, East Asia, the Middle East, and Africa. Gc protein is the major neutralizing target of AKAV and is often considered as an immunogen to prepare neutralizing antibodies. In this study, we prepared and characterized three monoclonal antibodies (mAbs), 4D1, 4E6, and 4F12, against the Gc protein of AKAV (TJ2016 strain). Western blot (WB) and indirect immunofluorescence assay (IFA) analysis proved that the mAbs can react with both the truncated recombinant AKAV Gc protein and the natural Gc protein produced in the AKAV-infected cells. Further research demonstrated that these mAbs possess neutralizing activity. We next defined a neutralizing epitope 1134SVQSFDGKL1142 by screening a panel of overlapping peptides spanning the truncated Gc protein (aa991â¼1232) using the generated neutralizing mAbs. Bioinformatic analysis shows that the neutralizing epitope is highly conserved across different genotypes of AKAV. The newly produced neutralizing mAbs and the identified neutralizing epitope in this study enrich the antigenic epitope information of the AKAV Gc protein and could have potential applications in the development of antigen and antibody detection systems that are specific to AKAV.
Subject(s)
Antibodies, Monoclonal , Antibodies, Neutralizing , Antibodies, Viral , Epitopes , Orthobunyavirus , Antibodies, Monoclonal/immunology , Antibodies, Neutralizing/immunology , Animals , Epitopes/immunology , Antibodies, Viral/immunology , Orthobunyavirus/immunology , Mice , Mice, Inbred BALB C , Neutralization TestsABSTRACT
In October 2023, bluetongue virus serotype 3 (BTV-3) emerged in Germany, where Schmallenberg virus is enzootic. We detected BTV-3 in 1 pool of Culicoides biting midges collected at the time ruminant infections were reported. Schmallenberg virus was found in many vector pools. Vector trapping and analysis could elucidate viral spread.
Subject(s)
Bluetongue virus , Bluetongue , Bunyaviridae Infections , Ceratopogonidae , Insect Vectors , Orthobunyavirus , Serogroup , Animals , Ceratopogonidae/virology , Ceratopogonidae/classification , Bluetongue virus/classification , Bluetongue virus/isolation & purification , Germany/epidemiology , Orthobunyavirus/classification , Orthobunyavirus/genetics , Orthobunyavirus/isolation & purification , Bluetongue/virology , Bluetongue/epidemiology , Bluetongue/transmission , Bunyaviridae Infections/veterinary , Bunyaviridae Infections/virology , Bunyaviridae Infections/transmission , Bunyaviridae Infections/epidemiology , Insect Vectors/virologyABSTRACT
Akabane virus (AKAV), Aino virus, Peaton virus, Sathuperi virus, and Shamonda virus are arthropod-borne viruses belonging to the order Elliovirales, family Peribunyaviridae, genus Orthobunyavirus. These viruses cause or may cause congenital malformations in ruminants, including hydranencephaly, poliomyelitis, and arthrogryposis, although their pathogenicity may vary among field cases. AKAV may cause relatively severe congenital lesions such as hydranencephaly in calves. Furthermore, strains of AKAV genogroups I and II exhibit different disease courses. Genogroup I strains predominantly cause postnatal viral encephalomyelitis, while genogroup II strains are primarily detected in cases of congenital malformation. However, the biological properties of AKAV and other orthobunyaviruses are insufficiently investigated in hosts in the field and in vitro. Here, we used an immortalized bovine brain cell line (FBBC-1) to investigate viral replication efficiency, cytopathogenicity, and host innate immune responses. AKAV genogroup II and Shamonda virus replicated to higher titers in FBBC-1 cells compared with the other viruses, and only AKAV caused cytopathic effects. These results may be associated with the severe congenital lesions in the brain caused by AKAV genogroup II. AKAV genogroup II strains replicated to higher titers in FBBC-1 cells than AKAV genogroup I strains, suggesting that genogroup II strains replicated more efficiently in fetal brain cells, accounting for the detection of the latter strains mainly in fetal infection cases. Therefore, FBBC-1 cells may serve as a valuable tool for investigating the virulence and tropism of the orthobunyaviruses for bovine neonatal brain tissues in vitro.